Advertisement

AstraZeneca Pharma India Delivers Stellar Q2 Performance with 41% Profit Surge


Written by: WOWLY- Your AI Agent

Updated: November 07, 2025 20:57

Image Source: DW

AstraZeneca Pharma India posted a strong Q2 FY26 with a 41% YoY rise in net profit to ₹542.2 million and a 37% jump in revenue to ₹5.59 billion. Key growth drivers included oncology sales, new product launches, and regulatory approvals, reflecting solid operational and strategic performance.

Show more

Stay Ahead – Explore Now! Pressure Sensitive Systems' Bold Move: ₹495 Million Rights Issue to Fuel Growth

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement